-
1
-
-
55449124897
-
-
CBTRUS Published by the Central Brain Tumor Registry of the United States. Accessed 8 July 2008
-
CBTRUS (2008) Statistical report: Primary brain tumors in the United States, 2000-2004. Published by the Central Brain Tumor Registry of the United States. http://www.cbtrus.org. Accessed 8 July 2008
-
(2008)
Statistical Report: Primary Brain Tumors in the United States, 2000-2004
-
-
-
2
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
doi: 10.1056/NEJMoa043330
-
Stupp R, Mason WP, Van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi: 10.1056/NEJMoa043330
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van den Bent, M.J.3
-
3
-
-
34547616670
-
Canadian recommendations for the treatment of glioblastoma multiforme
-
doi: 10.3747/co.2007.119
-
Mason WP, Del Maestro R, Eisenstat D et al (2007) Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 14:110-117. doi: 10.3747/co.2007.119
-
(2007)
Curr Oncol
, vol.14
, pp. 110-117
-
-
Mason, W.P.1
Del Maestro, R.2
Eisenstat, D.3
-
4
-
-
26444610107
-
Food and drug administration drug approval summary: Temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme
-
doi: 10.1158/1078-0432.CCR-05-0722
-
Cohen MH, Johnson JR, Pazdur R (2005) Food and drug administration drug approval summary: Temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 11:6767-6771. doi: 10.1158/1078-0432.CCR-05-0722
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6767-6771
-
-
Cohen, M.H.1
Johnson, J.R.2
Pazdur, R.3
-
5
-
-
33751358847
-
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature
-
doi: 10.1215/15228517-2006-003
-
Noronha V, Berliner N, Ballen KK, Lacy J, Kracher J, Baehring J, Henson JW (2006) Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature. Neurooncology 8:280-283. doi: 10.1215/15228517-2006-003
-
(2006)
Neurooncology
, vol.8
, pp. 280-283
-
-
Noronha, V.1
Berliner, N.2
Ballen, K.K.3
Lacy, J.4
Kracher, J.5
Baehring, J.6
Henson, J.W.7
-
6
-
-
14944377007
-
Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma
-
doi: 10.1007/s11060-004-2028-0
-
Su YW, Chang MC, Chiang MF, Hsieh RK (2005) Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neurooncol 71:315-318. doi: 10.1007/s11060-004-2028-0
-
(2005)
J Neurooncol
, vol.71
, pp. 315-318
-
-
Su, Y.W.1
Chang, M.C.2
Chiang, M.F.3
Hsieh, R.K.4
-
7
-
-
34548710872
-
Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with temozolomide
-
doi: 10.1007/s11060-007-9398-z
-
Jalali R, Singh P, Menon H, Gugral S (2007) Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with temozolomide. J Neurooncol 85:105-107. doi: 10.1007/s11060-007-9398-z
-
(2007)
J Neurooncol
, vol.85
, pp. 105-107
-
-
Jalali, R.1
Singh, P.2
Menon, H.3
Gugral, S.4
-
8
-
-
33646002315
-
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide
-
doi: 10.1016/S1470-2045(06)70696-9
-
Villano JL, Collins CA, Manasanch EE, Ramaprasad C, Besien KV (2006) Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol 7:436-438. doi: 10.1016/S1470-2045(06)70696-9
-
(2006)
Lancet Oncol
, vol.7
, pp. 436-438
-
-
Villano, J.L.1
Collins, C.A.2
Manasanch, E.E.3
Ramaprasad, C.4
Besien, K.V.5
-
9
-
-
51049083681
-
-
US Cancer Statistics Working Group US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. Accessed 8 July 2008
-
US Cancer Statistics Working Group (2007) United States cancer statistics: 1999-2004 incidence and mortality web-based report. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. http://www.cdc.gov/ uscs. Accessed 8 July 2008
-
(2007)
United States Cancer Statistics: 1999-2004 Incidence and Mortality Web-based Report
-
-
-
10
-
-
33847381884
-
Trends in palatine tonsillar cancer incidence and mortality rates in the United States
-
doi: 10.1111/j.1600-0528.2007.00299.x
-
Golas SM (2007) Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol 35:98-108. doi: 10.1111/j.1600-0528.2007.00299.x
-
(2007)
Community Dent Oral Epidemiol
, vol.35
, pp. 98-108
-
-
Golas, S.M.1
-
11
-
-
0345074110
-
Current management of tonsillar cancer
-
doi: 10.1016/S1368-8375(02)00085-4
-
Genden EM, Ferlito A, Scully C, Shaha AR, Higgins K, Rinaldo A (2003) Current management of tonsillar cancer. Oral Oncol 39:337-342. doi: 10.1016/S1368-8375(02)00085-4
-
(2003)
Oral Oncol
, vol.39
, pp. 337-342
-
-
Genden, E.M.1
Ferlito, A.2
Scully, C.3
Shaha, A.R.4
Higgins, K.5
Rinaldo, A.6
-
12
-
-
0027245615
-
Tonsillar carcinoma in a renal transplant patient treated with cyclosporine A
-
Swoboda A, Fabrizii V (1993) Tonsillar carcinoma in a renal transplant patient treated with cyclosporine A. Clin Nephrol 39:272-274
-
(1993)
Clin Nephrol
, vol.39
, pp. 272-274
-
-
Swoboda, A.1
Fabrizii, V.2
-
13
-
-
1842865745
-
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
-
doi: 10.1038/sj.cdd.4401359
-
Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11:448-457. doi: 10.1038/sj.cdd.4401359
-
(2004)
Cell Death Differ
, vol.11
, pp. 448-457
-
-
Kanzawa, T.1
Germano, I.M.2
Komata, T.3
Ito, H.4
Kondo, Y.5
Kondo, S.6
-
14
-
-
1342268265
-
Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide
-
Kanzawa T, Bedwell J, Kondo Y, Kondo S, Germano IM (2003) Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J Neurosurg 9:1047-1052
-
(2003)
J Neurosurg
, vol.9
, pp. 1047-1052
-
-
Kanzawa, T.1
Bedwell, J.2
Kondo, Y.3
Kondo, S.4
Germano, I.M.5
-
15
-
-
33645509873
-
Mutagenic potential of temozolomide in bone marrow cells in vivo
-
doi: 10.1182/blood-2005-09-3649
-
Geiger H, Schleimer D, Nattamai KJ, Dannenmann SR, Davies SM, Weiss BD (2006) Mutagenic potential of temozolomide in bone marrow cells in vivo. Blood 107:3010-3011. doi: 10.1182/blood-2005-09-3649
-
(2006)
Blood
, vol.107
, pp. 3010-3011
-
-
Geiger, H.1
Schleimer, D.2
Nattamai, K.J.3
Dannenmann, S.R.4
Davies, S.M.5
Weiss, B.D.6
-
16
-
-
34447563857
-
Glioblastoma in a patient with early-stage tonsil cancer
-
doi: 10.1200/JCO.2007.11.3530
-
Freedman RA, Wirth LJ, Chirieac LR, Huang EC (2007) Glioblastoma in a patient with early-stage tonsil cancer. J Clin Oncol 25:2848-2850. doi: 10.1200/JCO.2007.11.3530
-
(2007)
J Clin Oncol
, vol.25
, pp. 2848-2850
-
-
Freedman, R.A.1
Wirth, L.J.2
Chirieac, L.R.3
Huang, E.C.4
|